(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Must-See Attractions in Washington, D.C. - 2Overlooked infertility care should be part of national health services, says WHO
- 36 Financial plan 3D Printers with the Best Worth
- 4Cyber Monday 2025: Save over 70% on HBO Max with this Prime Video streaming deal
- 5How AI fixed the James Webb Space Telescope's blurry vision
- Flying without a Real ID? That'll soon cost you $45, TSA says.
- Most loved Seared Chicken: Which Chain Rules?
- When Would it be a good idea for you to Look for Help from a Criminal Legal counselor?
- How to watch 'A Charlie Brown Christmas' for less with this Apple TV Black Friday deal
- Climate engineering would alter the oceans, reshaping marine life – our new study examines each method’s risks
- Ukrainian Army Converts E38 BMW 7-Series Into Multiple Rocket Launch Platform
- Reports: Germany plans expansion of foreign intelligence powers
- The Ascent of Rousing Pioneers Who Formed History
- CDC changes kids' vaccine schedule, removing universal recommendation for some shots
